AAAAAA
Results: 1-25/39
Authors:
LIPPA CF
GALVIN J
CROUL S
FLANDERS K
HULETTE C
Citation: Cf. Lippa et al., TGF-B2 IMMUNOEXPRESSION IN PICKS-DISEASE - A RELATIONSHIP TO THE HOST-INFLAMMATORY RESPONSE, Brain pathology, 8(3), 1998, pp. 580-580
Authors:
LIPPA CF
JARRETT J
OCONNELL B
HULETTE C
Citation: Cf. Lippa et al., PICKS-DISEASE, APOE GENOTYPE, AND DISEASE DURATION - WHAT IS THE INFLUENCE ON FOCAL ATROPHY, Annals of neurology, 44(3), 1998, pp. 31-31
Authors:
LIPPA CF
JOHNSON R
SMITH TW
Citation: Cf. Lippa et al., THE MEDIAL TEMPORAL-LOBE IN DEMENTIA WITH LEWY BODIES - A COMPARATIVE-STUDY WITH ALZHEIMERS-DISEASE, Annals of neurology, 43(1), 1998, pp. 102-106
Authors:
FLANDERS KC
REN RF
LIPPA CF
Citation: Kc. Flanders et al., TRANSFORMING GROWTH FACTOR-BETA-S IN NEURODEGENERATIVE DISEASE, Progress in neurobiology, 54(1), 1998, pp. 71-85
Authors:
LIPPA CF
NEE LE
MORI H
STGEORGEHYSLOP P
Citation: Cf. Lippa et al., A-BETA-42 DEPOSITION PRECEDES OTHER CHANGES IN PS-1 ALZHEIMERS-DISEASE, Lancet, 352(9134), 1998, pp. 1117-1118
Authors:
GALVIN JE
LIPPA CF
Citation: Je. Galvin et Cf. Lippa, GLIAL-MICROGLIAL INTERACTIONS AND THE HOST INFLAMMATORY RESPONSE IN PICKS-DISEASE, Neurology, 50(4), 1998, pp. 3007-3007
Authors:
PERICSTEPCIC G
LIPPA CF
OCONNELL B
SMITH T
Citation: G. Pericstepcic et al., NIGRAL PATHOLOGY DIFFERENTIATES DEMENTIA WITH LEWY BODIES FROM ALZHEIMERS-DISEASE, Neurology, 50(4), 1998, pp. 6108-6108
Authors:
LIPPA CF
BREEN A
OCONNELL B
SMITH TW
MORI H
Citation: Cf. Lippa et al., BETA-AMYLOID-40 AND BETA-AMYLOID-42 DEPOSITION IN DEMENTIA WITH LEWY BODIES - COMPARISON WITH ALZHEIMERS-DISEASE AND AGING, Neurology, 50(4), 1998, pp. 13005-13005
Authors:
DUDA J
LIPPA CF
CROUL S
NEE L
FLANDERS K
Citation: J. Duda et al., ESTROGEN AND ALZHEIMERS-DISEASE - COULD THE TGF-BETA SYSTEM BE INVOLVED, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 106-106
Authors:
LIPPA CF
OCONNELL B
SMITH TW
ISHII K
MORI H
Citation: Cf. Lippa et al., DEMENTIA WITH LEWY BODIES - INFLUENCE OF APOE GENOTYPE ON A-BETA(-40)AND A-BETA(-42) DEPOSITION, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 186-186
Authors:
LIPPA CF
FUJIWARA H
MANN DMA
GIASSON B
BABA M
SCHMIDT ML
NEE LE
OCONNELL B
POLLEN DA
GEORGEHYSLOP PS
GHETTI B
NOCHLIN D
BIRD TD
CAIRNS NJ
LEE VMY
IWATSUBO T
TROJANOWSKI JQ
Citation: Cf. Lippa et al., LEWY BODIES CONTAIN ALTERED ALPHA-SYNUCLEIN IN BRAINS OF MANY FAMILIAR ALZHEIMERS-DISEASE PATIENTS WITH MUTATIONS IN PRESENILIN AND AMYLOIDPRECURSOR PROTEIN GENES, The American journal of pathology, 153(5), 1998, pp. 1365-1370
Authors:
LIPPA CF
JOHNSON R
SMITH TW
Citation: Cf. Lippa et al., MEDIAL TEMPORAL-LOBE AREA HELPS DIFFERENTIATE LEWY BODY DISEASE FROM ALZHEIMERS-DISEASE, Annals of neurology, 42(3), 1997, pp. 24-24
Authors:
LIPPA CF
OCONNELL B
NEE L
SMITH TW
Citation: Cf. Lippa et al., DEMENTIA WITH PARKINSONISM - ALZHEIMERS-DISEASE OR LEWY BODY DISEASE, Neurology, 48(3), 1997, pp. 14005-14005
Authors:
LIPPA CF
SMITH TW
SAUNDERS AM
HULETTE C
PULASKISALO D
ROSES AD
Citation: Cf. Lippa et al., APOLIPOPROTEIN E-EPSILON-2 AND ALZHEIMERS-DISEASE - GENOTYPE INFLUENCES PATHOLOGICAL PHENOTYPE, Neurology, 48(2), 1997, pp. 515-519
Authors:
LIPPA CF
PULASKISALO D
DICKSON DW
SMITH TW
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE, LEWY BODY DISEASE AND AGING - A COMPARATIVE-STUDYOF THE PERFORANT PATHWAY, Journal of the neurological sciences, 147(2), 1997, pp. 161-166
Authors:
LIPPA CF
OCONNELL BG
STEPCIC G
SMITH TW
Citation: Cf. Lippa et al., PARKINSONISM IN THE ALZHEIMERS PATIENT - WHAT IS THE ROLE OF BASAL GANGLIA PATHOLOGY, Journal of neuropathology and experimental neurology, 56(5), 1997, pp. 86-86
Authors:
LIPPA CF
SMITH TW
PULASKISALO D
DICKSON DW
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE VERSUS LEWY BODY DISEASE - DIFFERENCES IN PERFORANT PATHWAY PATHOLOGY, Annals of neurology, 40(3), 1996, pp. 47-47
Authors:
LIPPA CF
FRASER PE
NEE L
ALEXANDER M
SALO D
STGEORGEHYSLOP P
Citation: Cf. Lippa et al., S182 AND E5-1 IMMUNOEXPRESSION IN NORMAL AGING AND ALZHEIMERS-DISEASE, Neurology, 46(2), 1996, pp. 23002-23002
Authors:
LIPPA CF
SAUNDERS AM
SMITH TW
SWEARER JM
DRACHMAN DA
GHETTI B
NEE L
PULASKISALO D
DICKSON D
ROBITAILLE Y
BERGERON C
CRAIN B
BENSON MD
FARLOW M
HYMAN BT
STGEORGEHYSLOP P
ROSES AD
POLLEN DA
Citation: Cf. Lippa et al., FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE - NEUROPATHOLOGY CANNOT EXCLUDE A FINAL COMMON PATHWAY, Neurology, 46(2), 1996, pp. 406-412
Authors:
VODOVOTZ Y
LUCIA MS
FLANDERS KC
CHESLER L
XIE QW
SMITH TW
WEIDNER J
MUMFORD R
WEBBER R
NATHAN C
ROBERTS AB
LIPPA CF
SPORN MB
Citation: Y. Vodovotz et al., INDUCIBLE NITRIC-OXIDE SYNTHASE IN TANGLE-BEARING NEURONS OF PATIENTSWITH ALZHEIMERS-DISEASE, The Journal of experimental medicine, 184(4), 1996, pp. 1425-1433
Authors:
LIPPA CF
SMITH TW
FLANDERS KC
Citation: Cf. Lippa et al., TRANSFORMING GROWTH-FACTOR-BETA - NEURONAL AND GLIAL EXPRESSION IN CNS DEGENERATIVE DISEASES, Neurodegeneration, 4(4), 1995, pp. 425-432
Authors:
LIPPA CF
SMITH TW
NEE L
ROBITAILLE Y
CRAIN B
DICKSON D
PULASKISALO D
POLLEN DA
Citation: Cf. Lippa et al., FAMILIAL ALZHEIMERS-DISEASE AND CORTICAL LEWY BODIES - IS THERE A GENETIC SUSCEPTIBILITY FACTOR, Dementia, 6(4), 1995, pp. 191-194
Authors:
FLANDERS KC
LIPPA CF
POLLEN DA
SPORN MB
Citation: Kc. Flanders et al., ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA IN ALZHEIMERS-DISEASE, Journal of cellular biochemistry, 1995, pp. 103-103
Authors:
LIPPA CF
FRASER PE
NEE L
ALEXANDER M
SALO D
STGEORGEHYSLOP P
Citation: Cf. Lippa et al., IMMUNOEXPRESSION OF A POLYCLONAL ANTIBODY-DIRECTED AGAINST THE S182 AND E5-1 PROTEINS, Annals of neurology, 38(6), 1995, pp. 6-6
Authors:
LIPPA CF
SWEARER J
SALO D
DRACHMAN DA
Citation: Cf. Lippa et al., ALZHEIMERS-DISEASE WITH AND WITHOUT LEWY BODIES - CAN THEY BE DISTINGUISHED AT INITIAL PRESENTATION, Annals of neurology, 38(2), 1995, pp. 290-290